Results 171 to 180 of about 37,561 (261)

Primary sclerosing cholangitis pathogenesis revisited: EBV-idence of immune dysregulation. [PDF]

JHEP Rep
Ronca V, Londoño MC.
europepmc   +1 more source

Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease [PDF]

, 2006

core   +1 more source

Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background and Aims Hepatic decompensation represents a critical transition in cirrhosis, leading to increased morbidity, mortality and healthcare utilisation. Identifying patients at risk of decompensation remains a clinical challenge. We aimed to develop and validate XGBoost models to predict hepatic decompensation at multiple time points ...
Micah Grubert Van Iderstine, Sem Perez, Gregory S. Jackson, Tyler Szun, Caelan Stephanson, Megan Weisshaar, Gerald Y. Minuk, Nabiha Faisal   +7 more
wiley   +1 more source

Effect of Hormone Replacement Therapy on Liver and Cardiometabolic Outcomes in Peri‐Menopausal MASLD

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. Menopause is associated with increased hepatic fat deposition and thus metabolic dysfunction, contributing to heightened risk of progressive liver and cardiovascular disease.
Alex E. Henney, Jo Wilson, David R. Riley, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Radiomics-Based Prognostication in Primary Sclerosing Cholangitis: A Proof-of-Concept Study. [PDF]

Liver Int
Cristoferi L, Maino C, Bernasconi DP, Ripamonti I, Scaravaglio M, Savino A, Pesatori E, Gerussi A, Nofit E, Falco O, D'Amato D, Gallivanone F, Alberzoni C, Viganò R, Mazzarelli C, Belli LS, Dinelli ME, Mutignani M, Valsecchi MG, Corso R, Invernizzi P, Carbone M, Ippolito D, Bernardi E.   +23 more
europepmc   +1 more source

Liver transplantation [PDF]

, 1983
Koep, LJ, Starzl, TE
core  

Elevated Polyreactive Immunoglobulin G in Immune‐Mediated Liver Injuries With the Need for Immunosuppressive Therapy

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background & Aims The distinction of drug‐induced liver injury (DILI), drug‐induced autoimmune‐like hepatitis (DI‐ALH), and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker in AIH.
Theresa Kirchner, George N. Dalekos, Kalliopi Zachou, Mercedes Robles‐Díaz, Raúl J. Andrade, Marcial Sebode, Ansgar Lohse, Maciej K. Janik, Piotr Milkiewicz, Mirjam Kolev, Nasser Semmo, Tony Bruns, Tom Jg. Gevers, Benedetta Terziroli Beretta‐Piccoli, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel, pIgG study group   +18 more
wiley   +1 more source

Periductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis. [PDF]

BMC Med Imaging
Selvaraj EA, Ba-Ssalamah A, Poetter-Lang S, Paun B, Ridgway GR, Beyer C, Andersson A, Brady SM, Pansini M, Culver EL, Bailey A, DPhil MP.   +11 more
europepmc   +1 more source

Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency

Pediatric Allergy and Immunology, Volume 37, Issue 4, April 2026.
Abstract Background A20 haploinsufficiency (HA20) is an autoinflammatory disease driven by pathogenic variants in TNFAIP3, which plays a crucial role in regulating immune responses. The clinical manifestations of HA20 resemble those of inflammatory bowel disease (IBD), with prominent gastrointestinal (GI) involvement.
Inès Elhani, Marius Bredon, Diana Enea, Aurore Desmons, Lionel Arrive, Céline Bazille, Antoine Lefevre, Achille Aouba, Adrien Bigot, Claire de Moreuil, Iria Alonso, Hélène Blasco, Laura Creusot, Camille Dupuy, Patrick Emond, Pranvera Krasniqi, Antonin Lamaziere, Cyriane Oeuvray, Dominique Rainteau, Magali Svrcek, Nathalie Rolhion, Harry Sokol, Sophie Georgin‐Lavialle   +22 more
wiley   +1 more source

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. [PDF]

Gastro Hep Adv
Urquhart SA, Ramesh PR, Kane SV, Raffals LE, Loftus EV, Bruining DH, Stephens MC, Eaton JE, Lazaridis KN, Hashash JG, Ha CY, Harmsen WS, Coelho-Prabhu N.   +12 more
europepmc   +1 more source